Johannes Kluwe

8.2k total citations · 2 hit papers
60 papers, 5.0k citations indexed

About

Johannes Kluwe is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Johannes Kluwe has authored 60 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Epidemiology, 32 papers in Hepatology and 11 papers in Surgery. Recurrent topics in Johannes Kluwe's work include Liver Disease Diagnosis and Treatment (43 papers), Liver Disease and Transplantation (17 papers) and Liver physiology and pathology (11 papers). Johannes Kluwe is often cited by papers focused on Liver Disease Diagnosis and Treatment (43 papers), Liver Disease and Transplantation (17 papers) and Liver physiology and pathology (11 papers). Johannes Kluwe collaborates with scholars based in Germany, United States and Italy. Johannes Kluwe's co-authors include Robert F. Schwabe, Samuele De Minicis, Ekihiro Seki, David A. Brenner, Christoph H. Österreicher, Yosuke Osawa, Ali Mencin, Geum‐Youn Gwak, Jean‐Philippe Pradère and Yonghui Zhang and has published in prestigious journals such as Journal of Clinical Investigation, Nature Medicine and Gastroenterology.

In The Last Decade

Johannes Kluwe

60 papers receiving 4.9k citations

Hit Papers

TLR4 enhances TGF-β signaling and hepatic fibrosis 2007 2026 2013 2019 2007 2013 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. TLR4 enhances TGF-β signaling and hepatic fibrosis
    2007 1.6k citations Ekihiro Seki, Samuele De Minicis et al. profile →
  2. Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice
    2013 482 citations Johannes Kluwe, Samuele De Minicis et al. Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Johannes Kluwe Germany 25 3.0k 2.5k 1.2k 828 728 60 5.0k
Yong‐Han Paik South Korea 37 3.7k 1.2× 3.7k 1.5× 1.4k 1.2× 1.0k 1.3× 686 0.9× 144 6.4k
Dianne H. Dapito United States 17 2.2k 0.7× 2.0k 0.8× 1.3k 1.1× 769 0.9× 735 1.0× 18 4.3k
Carmelo García‐Monzón Spain 36 2.9k 1.0× 1.5k 0.6× 1.2k 1.1× 513 0.6× 464 0.6× 102 4.6k
Wing‐Kin Syn United States 39 2.9k 1.0× 2.3k 0.9× 1.7k 1.5× 1.1k 1.3× 372 0.5× 94 5.4k
Xiong Ma China 40 2.5k 0.8× 2.2k 0.9× 1.3k 1.1× 1.3k 1.6× 855 1.2× 177 5.0k
Ricardo Moreno‐Otero Spain 44 3.2k 1.1× 2.8k 1.2× 894 0.8× 861 1.0× 503 0.7× 155 5.7k
Ingmar Mederacke Germany 23 2.7k 0.9× 2.6k 1.1× 1.2k 1.0× 776 0.9× 564 0.8× 46 4.6k
Detlef Schuppan Germany 43 4.0k 1.3× 3.7k 1.5× 1.4k 1.2× 1.4k 1.8× 557 0.8× 103 7.2k
Katsutoshi Tokushige Japan 39 4.3k 1.4× 2.7k 1.1× 851 0.7× 881 1.1× 421 0.6× 204 5.6k
Christoph H. Österreicher Austria 26 3.2k 1.1× 2.7k 1.1× 2.0k 1.7× 1.2k 1.4× 1.1k 1.5× 37 6.8k

Countries citing papers authored by Johannes Kluwe

Since Specialization
Citations

This map shows the geographic impact of Johannes Kluwe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johannes Kluwe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johannes Kluwe more than expected).

Fields of papers citing papers by Johannes Kluwe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johannes Kluwe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johannes Kluwe. The network helps show where Johannes Kluwe may publish in the future.

Co-authorship network of co-authors of Johannes Kluwe

This figure shows the co-authorship network connecting the top 25 collaborators of Johannes Kluwe. A scholar is included among the top collaborators of Johannes Kluwe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johannes Kluwe. Johannes Kluwe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Piecha, Felix, Ann‐Kathrin Ozga, Christoph Riedel, et al.. (2024). Recompensation of Liver Cirrhosis by TIPS Reduces Epithelial Cell Death Markers, Translating Into Improved Clinical Outcome. Liver International. 45(4). e16156–e16156. 1 indexed citations
2.
3.
4.
Meyer, Simon F. De, Markus Heine, L. Eissing, et al.. (2023). TREM2 Regulates the Removal of Apoptotic Cells and Inflammatory Processes during the Progression of NAFLD. Cells. 12(3). 341–341. 28 indexed citations
5.
Piecha, Felix, Ann‐Kathrin Ozga, Daniel Benten, et al.. (2023). Preoperative TIPS and in-hospital mortality in patients with cirrhosis undergoing surgery. JHEP Reports. 6(1). 100914–100914. 9 indexed citations
6.
Pischke, Sven, Ulrike Peters, Julian Schulze zur Wiesch, et al.. (2023). High prevalence of periodontal disease in patients with NASH- possible association of poor dental health with NASH severity. Annals of Hepatology. 28(2). 100887–100887. 3 indexed citations
7.
Wehmeyer, Malte H., Thomas Horvatits, Anika Buchholz, et al.. (2022). Stop of proton-pump inhibitor treatment in patients with liver cirrhosis (STOPPIT): study protocol for a prospective, multicentre, controlled, randomized, double-blind trial. Trials. 23(1). 302–302. 8 indexed citations
8.
Fründt, Thorben, Dominik Nörz, Thomas Theo Brehm, et al.. (2021). Low incidence of COVID-19 in a prospective cohort of patients with liver cirrhosis and hepatocellular carcinoma treated at a tertiary medical center during the 2020 pandemic. PLoS ONE. 16(12). e0258450–e0258450. 2 indexed citations
9.
Drolz, Andreas, Stefan Wolter, Malte H. Wehmeyer, et al.. (2021). Performance of non-invasive fibrosis scores in non-alcoholic fatty liver disease with and without morbid obesity. International Journal of Obesity. 45(10). 2197–2204. 34 indexed citations
10.
Radunski, Ulf K, Johannes Kluwe, Gunnar Lund, et al.. (2021). Cardiovascular magnetic resonance demonstrates structural cardiac changes following transjugular intrahepatic portosystemic shunt. Scientific Reports. 11(1). 12719–12719. 8 indexed citations
11.
Piecha, Felix, Ann‐Kathrin Ozga, Malte H. Wehmeyer, et al.. (2021). Evolution of liver stiffness and post-treatment surveillance by liver elastography for HCV patients in the DAA era. Scandinavian Journal of Gastroenterology. 56(7). 840–848. 4 indexed citations
12.
Fuhrmann, Valentin, Theresia Weber, Kevin Roedl, et al.. (2020). Advanced organ support (ADVOS) in the critically ill: first clinical experience in patients with multiple organ failure. Annals of Intensive Care. 10(1). 96–96. 21 indexed citations
13.
14.
Ittrich, Harald, et al.. (2017). TIMP-1 is upregulated, but not essential in hepatic fibrogenesis and carcinogenesis in mice. Scientific Reports. 7(1). 714–714. 50 indexed citations
15.
Wehmeyer, Malte H., Birgit‐Christiane Zyriax, Bettina Jagemann, et al.. (2016). Nonalcoholic fatty liver disease is associated with excessive calorie intake rather than a distinctive dietary pattern. Medicine. 95(23). e3887–e3887. 85 indexed citations
16.
Beisel, Claudia, Julian Schulze zur Wiesch, Malte H. Wehmeyer, et al.. (2016). Infections complicating severe alcoholic hepatitis:Enterococcusspecies represent the most frequently identified pathogen. Scandinavian Journal of Gastroenterology. 51(7). 807–813. 5 indexed citations
17.
Barikbin, R, Daniel Neureiter, Annette Erhardt, et al.. (2011). Induction of Heme Oxygenase 1 Prevents Progression of Liver Fibrosis in Mdr2 Knockout Mice. Hepatology. 55(2). 553–562. 51 indexed citations
18.
Seki, Ekihiro, Samuele De Minicis, Geum‐Youn Gwak, et al.. (2009). CCR1 and CCR5 promote hepatic fibrosis in mice. Journal of Clinical Investigation. 119(7). 1858–70. 357 indexed citations
19.
Kluwe, Johannes, Ali Mencin, & Robert F. Schwabe. (2008). Toll-like receptors, wound healing, and carcinogenesis. Journal of Molecular Medicine. 87(2). 125–138. 119 indexed citations
20.
Kluwe, Johannes & Ansgar W. Lohse. (2005). Therapieoptionen für die nicht-alkoholinduzierte Fettleber und Fettleberhepatitis. Der Internist. 46(12). 1324–1330. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yong‐Han Paik Breakdown of academic impact, for papers by Dianne H. Dapito Breakdown of academic impact, for papers by Carmelo García‐Monzón Breakdown of academic impact, for papers by Wing‐Kin Syn Breakdown of academic impact, for papers by Xiong Ma Breakdown of academic impact, for papers by Ricardo Moreno‐Otero Breakdown of academic impact, for papers by Ingmar Mederacke Breakdown of academic impact, for papers by Detlef Schuppan Breakdown of academic impact, for papers by Katsutoshi Tokushige Breakdown of academic impact, for papers by Christoph H. Österreicher
Rankless by CCL
2026